Minnesota Proposes to Reduce Opioid Product Registration Fees Related to Hospitals
FDA Law Blog
JUNE 28, 2021
On June 26, 2021, during the Minnesota legislature’s special session, the Minnesota House of Representatives passed HF33, an omnibus health and human services bill. If enacted, Article 5, Section 6 of HF33 would provide for a reduction to the State’s opiate product registration fee. 151.066, Subd.
Let's personalize your content